SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-24-027508
Filing Date
2024-03-29
Accepted
2024-03-28 20:11:52
Documents
94
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0200415-10k_pasithea.htm   iXBRL 10-K 1500766
2 DESCRIPTION OF SECURITIES ea020041501ex4-7_pasithea.htm EX-4.7 33661
3 CONSULTING AGREEMENT BETWEEN PASITHEA THERAPEUTICS CORP. AND DR. LAWRENCE STEINM ea020041501ex10-20_pasithea.htm EX-10.20 40486
4 SUBSIDIARIES OF THE REGISTRANT ea020041501ex21-1_pasithea.htm EX-21.1 1466
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (MARCUM LLP) ea020041501ex23-1_pasithea.htm EX-23.1 2105
6 CERTIFICATION ea020041501ex31-1_pasithea.htm EX-31.1 9255
7 CERTIFICATION ea020041501ex31-2_pasithea.htm EX-31.2 9277
8 CERTIFICATION ea020041501ex32-1_pasithea.htm EX-32.1 4141
9 CERTIFICATION ea020041501ex32-2_pasithea.htm EX-32.2 4393
10 CLAWBACK POLICY ea020041501ex97-1_pasithea.htm EX-97.1 24712
  Complete submission text file 0001213900-24-027508.txt   7306383

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE ktta-20231231.xsd EX-101.SCH 68750
12 XBRL CALCULATION FILE ktta-20231231_cal.xml EX-101.CAL 64107
13 XBRL DEFINITION FILE ktta-20231231_def.xml EX-101.DEF 358144
14 XBRL LABEL FILE ktta-20231231_lab.xml EX-101.LAB 649522
15 XBRL PRESENTATION FILE ktta-20231231_pre.xml EX-101.PRE 354170
98 EXTRACTED XBRL INSTANCE DOCUMENT ea0200415-10k_pasithea_htm.xml XML 682239
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

IRS No.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40804 | Film No.: 24801581
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)